ArticleAging2019

MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.

Gang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.